ArticleVaccines2022

Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report.

Federica Calò et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.